STOLFI, CARMINE
 Distribuzione geografica
Continente #
NA - Nord America 19.506
EU - Europa 1.710
AS - Asia 1.009
SA - Sud America 7
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 22.239
Nazione #
US - Stati Uniti d'America 19.486
SG - Singapore 582
IT - Italia 310
DE - Germania 269
CN - Cina 264
IE - Irlanda 234
UA - Ucraina 230
RU - Federazione Russa 163
SE - Svezia 137
GB - Regno Unito 114
KR - Corea 97
FR - Francia 81
FI - Finlandia 70
PL - Polonia 35
BE - Belgio 22
ID - Indonesia 20
CA - Canada 14
HK - Hong Kong 12
AT - Austria 8
JP - Giappone 7
IN - India 6
CZ - Repubblica Ceca 5
ES - Italia 5
LT - Lituania 5
NL - Olanda 4
RO - Romania 4
BR - Brasile 3
CH - Svizzera 3
CL - Cile 3
DM - Dominica 3
EG - Egitto 3
GR - Grecia 3
IR - Iran 3
NO - Norvegia 3
PH - Filippine 3
TR - Turchia 3
DK - Danimarca 2
EU - Europa 2
IL - Israele 2
MK - Macedonia 2
MX - Messico 2
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
BT - Bhutan 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
PA - Panama 1
PK - Pakistan 1
SA - Arabia Saudita 1
TW - Taiwan 1
VN - Vietnam 1
Totale 22.239
Città #
Woodbridge 5.375
Wilmington 4.827
Houston 4.610
Fairfield 831
Singapore 502
Ann Arbor 477
Chandler 475
Ashburn 406
Seattle 321
Cambridge 291
Dublin 212
Jacksonville 212
Medford 171
Rome 156
Santa Clara 137
Dearborn 130
Beijing 101
New York 95
Lawrence 75
San Diego 48
Kraków 34
Zhengzhou 34
Menlo Park 29
Moscow 29
Mülheim 26
London 24
Brussels 22
Helsinki 19
Jakarta 19
Boardman 17
Milan 17
Seoul 17
Council Bluffs 16
Munich 15
Redwood City 15
Hangzhou 14
Mountain View 14
Colorado Springs 12
Shanghai 12
Norwalk 11
Palo Alto 11
Toronto 10
Nanjing 9
Kilburn 8
Los Angeles 8
San Mateo 8
Guangzhou 7
Saint Petersburg 7
Verona 7
North Hollywood 6
Nürnberg 6
University Park 6
Brno 5
Cedarhurst 5
Creede 5
Hanover 5
Hong Kong 5
Naples 5
Auburn Hills 4
Bari 4
Chengdu 4
Del Norte 4
Duncan 4
Falls Church 4
Frankfurt am Main 4
Hefei 4
Nanchang 4
Nepi 4
Nuremberg 4
Vienna 4
Atlanta 3
Fuzhou 3
Indiana 3
Kunming 3
Lappeenranta 3
Lusciano 3
Manila 3
Prescot 3
Pune 3
Roseau 3
Shenyang 3
Tokyo 3
Washington 3
Aarhus 2
Adana 2
Alexandria 2
Amsterdam 2
Center 2
Chicago 2
Durham 2
Engelhard 2
Espoo 2
Florence 2
Genazzano 2
Hounslow 2
Ivry-sur-seine 2
Jinan 2
Lausanne 2
Licata 2
Mentana 2
Totale 20.092
Nome #
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 479
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 470
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 454
A functional role for Smad7 in sustaining colon cancer cell growth and survival 448
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 441
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 440
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 434
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 434
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 432
The dual role of Smad7 in the control of cancer growth and metastasis 430
Regulation of gut inflammation and Th17 cell response by interleukin-21 427
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 425
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 423
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 422
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 422
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 420
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 418
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 417
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 417
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 416
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 412
Colorectal cancer chemoprevention by mesalazine and its derivatives 411
Autocrine regulation of IL-21 production in human T lymphocytes 410
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 406
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 402
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 400
The dual role of inflammation in colon carcinogenesis 397
Collagen matrix injection combined with flap repair for complex anal fistula 396
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 390
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 389
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 386
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 386
Role of TH17 cytokines in the control of colorectal cancer 384
Detection methods and clinical significance of free peritoneal tumor cells found during colorectal cancer surgery. 383
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages 376
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 372
Molecular basis of the potential of mesalazine to prevent colorectal cancer 363
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer 363
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 362
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis 356
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression 355
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease 334
Smad7 positively regulates keratinocyte proliferation in psoriasis 332
IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis 318
Interleukin-21 in cancer immunotherapy: Friend or foe? 315
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 315
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 298
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death 293
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 279
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 276
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 194
Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide 192
Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells 173
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 166
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 161
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 136
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells 133
Molecular targets of mesalazine in colorectal cancer 131
{STAT}3 Interactors as Potential Therapeutic Targets for Cancer Treatment 123
Follistatin-like protein 1 sustains colon cancer cell growth and survival 91
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 90
NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals 88
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 87
Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System 77
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 75
Association between celiac disease and cancer 74
The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis 71
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis 63
Aptamer linked to DNA nanostructures diverts its traffic inside cancer cells and improves its therapeutic efficacy 63
Role of interleukin-34 in cancer 59
RORγt-Expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells 59
null 56
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis 51
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 51
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 49
null 43
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases 43
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 42
The AtMYB11 gene from Arabidopsis is expressed in meristematic cells and modulates growth in planta and organogenesis in vitro 41
Impact of food additives on gut homeostasis 30
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 30
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells 28
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 26
Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials 26
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 24
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut† 21
TRAIL-Sensitizing Effects of Flavonoids in Cancer 20
null 19
null 18
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 18
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 17
Anthelmintic Drugs as Emerging Immune Modulators in Cancer 15
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance 15
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier 13
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 12
Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders? 10
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue “State-of-the-Art Molecular Oncology in Italy” 9
Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut 9
Smad7 as a positive regulator of intestinal inflammatory diseases 8
Editorial for the Special Issue “Latest Review Papers in Molecular Oncology 2023” 8
Totale 22.586
Categoria #
all - tutte 51.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.320 0 0 0 0 0 617 520 498 499 461 326 399
2020/20214.039 314 390 852 460 341 441 427 363 91 176 122 62
2021/2022870 45 97 57 19 28 61 59 28 90 76 70 240
2022/20231.173 102 109 33 144 122 225 96 91 112 40 73 26
2023/2024460 55 18 26 16 47 117 21 84 4 4 3 65
2024/20251.354 78 565 328 189 57 137 0 0 0 0 0 0
Totale 22.627